ArticleRevista medica del Instituto Mexicano del Seguro Social2026
[Clinical and obstetric characteristics in women with multiple sclerosis during pregnancy].
Article in Revista medica del Instituto Mexicano del Seguro Social, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Multiple sclerosis (MS) is an inflammatory demyelinating disease that affects the central nervous system. It is the second leading cause of disability in young adults, with a higher prevalence in women, and 70% to 75% of these women are of reproductive age. Objective: To identify the clinical characteristics of pregnant patients with multiple sclerosis. Material and methods: Retrospective cohort. Medical records from the Neurology Department of the Specialty Hospital, CMNO of the Mexican Social Security Institute were reviewed from January 2001 to December 2022. Women diagnosed with MS who had previously been pregnant were identified. Results: Twenty-two patients who had been pregnant after their MS diagnosis were recruited. The age at diagnosis was 25.50 ± 6.7 years, and the age at pregnancy was 31.94 ± 5.54 years. No significant changes (p = 0.636) were observed on the Expanded Disability Status Scale (EDSS) during pregnancy. The most used medication was glatiramer acetate. 77.8% of patients did not experience disease relapses during pregnancy. Conclusions: Pregnant women with multiple sclerosis treated at the National Western Medical Center showed clinical stability according to the EDSS before, during, and after pregnancy (p = 0.636). Most patients did not experience disease relapses during pregnancy, nor did they report complications during the immediate postpartum period.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.